CAncer Risk and INsulin analoGues (CARING) project First published 10/12/2013 Last updated 23/04/2024 EU PAS number:EUPAS5383 Study Finalised
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University Netherlands First published:01/03/2010 Last updated 23/05/2024 Institution Educational Institution ENCePP partner
Tampere University Hospital Finland First published:01/02/2024 Last updated 01/02/2024 Institution Educational Institution Hospital/Clinic/Other health care facility
Centre for Pharmacoepidemiology, Karolinska Institutet (CPE-KI) Sweden First published:24/03/2010 Last updated 23/04/2024 Institution Educational Institution Laboratory/Research/Testing facility Not-for-profit ENCePP partner
Department of Chronic Diseases, Pharmacoepidemiologic Research Group, Norwegian Institute of Public Health (NIPH) Norway First published:29/04/2010 Last updated 06/05/2024 Institution Laboratory/Research/Testing facility Other ENCePP partner
CAncer Risk and INsulin analoGues (CARING) Denmark Finland Netherlands Norway Sweden First published:13/12/2013 Last updated 13/03/2024 Network ENCePP partner